What challenges does the advanced therapies sector face?
Drug Discovery World
JANUARY 30, 2024
Dr Naldini open new doors for cures for otherwise untreatable genetic diseases with the full impact of his work still untapped”, she said. High-cost materials: Specialised equipment, reagents, and cell culture media significantly contribute to the overall cost. Developing more efficient and affordable alternatives is key.
72 
Let's personalize your content